Capstan Medical has reeled in $110 million to continue its mission of bringing robotic surgery to a previously untouched sector of medicine: the replacement of cardiac valves to treat structural heart disease. The series C amount nearly triples the Santa Cruz, California-based company’s previous venture capital fundraising, in which it…